Efficacy of maintenance or consolidation therapy for multiple myeloma based on proteasome inhibitors: a meta-analysis
Abstract Background This study assessed the efficacy of proteasome inhibitors (PIs) in both maintenance and consolidation therapies for MM patients. Methods A comprehensive search across multiple databases was conducted, including PubMed, Science Direct, Google Scholar, CNKI, EMBASE, Web of Science,...
Saved in:
| Main Authors: | Dan Wu, Feiqing Wang, Xu Yang, Bo Yang, Juan Chen, Jinyang Cheng, Bo Wei, Xiaoshuang Yuan, Tingting Tian, Zhenhua Liu, Zhixu He, Yang Liu, Yanju Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-04-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02304-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New proteasome inhibitors in the management of multiple myeloma
by: S. V. Semochkin
Published: (2019-07-01) -
Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma
by: Wenjiao Tang, et al.
Published: (2024-07-01) -
ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF‐κB in multiple myeloma
by: Jifeng Jiang, et al.
Published: (2020-10-01) -
Proteasome inhibitors: situation and prospects (literature review and own data)
by: A. A. Rukavitsyn, et al.
Published: (2016-10-01) -
Serum indicators in functional high-risk multiple myeloma patients undertaking proteasome inhibitors therapy: a retrospective study
by: Linquan Zhan, et al.
Published: (2024-12-01)